AUA Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

AUA Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30	Closed	-$996	–	350
2022 Q4	$996	Hold	30	–	–	﹤0.01%	308
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	342
2022 Q2	$1K	Buy	30 +7	+30%	+$189	﹤0.01%	357
2022 Q1	$1K	Hold	23	–	–	﹤0.01%	362
2021 Q4	$0	Buy	23 +9	+64%	+$173	﹤0.01%	363
2021 Q3	$0	Sell	14 -88	-86%	-$1.75K	﹤0.01%	359
2021 Q2	$2K	Sell	102 -7	-6%	-$148	﹤0.01%	296
2021 Q1	$3K	Hold	109	–	–	﹤0.01%	266
2020 Q4	$2K	Buy	109 +24	+28%	+$448	﹤0.01%	293
2020 Q3	$1K	Buy	+85	New	+$1.65K	﹤0.01%	322

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AUA Capital Management's VIVO Position: Q1 2023 in Review

AUA Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 30 shares — an estimated $996 sold.

AUA Capital Management first reported a position in VIVO in Q3 2020 and held it in 10 quarters. The position peaked at $3K in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

AUA Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
AUA Capital Management sold 30 Meridian Bioscience Inc shares in Q1 2023, an estimated $996.
AUA Capital Management first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 10 quarters.
AUA Capital Management's Meridian Bioscience Inc position peaked at $3K in Q1 2021.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on AUA Capital Management's 13F filing for Q1 2023, filed 20 Apr 2023.